• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Scripps Research Institute

Artificial intelligence and medicine: Is it overhyped?

March 22, 2019 By Fink Densford

Artificial intelligence raises exciting possibilities for healthcare, but are companies promising more than they can deliver? AI could possibly fuel the future of medtech, enabling such thrilling innovations as implanted devices that instantly react to minute changes, software that can identify the best treatment options for individuals facing life-threatening conditions and fully-functioning autonomous surgical systems. […]

Filed Under: Business/Financial News, Featured, Health Information Technology, Research & Development, Software / IT Tagged With: AI, artificial intelligence, HeartFlow, IBM Watson Health, idx, Scripps Research Institute

Nvidia, Scripps look to tackle atrial fibrillation with deep learning

October 23, 2018 By Sarah Faulkner

Nvidia (NSDQ:NVDA) and Scripps Research Translational Institute announced today that the groups are teaming up to develop deep learning tools to process genomic and medical sensor data. The tech giant and the non-profit research org hope to leverage artificial intelligence to prevent disease and accelerate biomedical research efforts. The use of AI in healthcare is […]

Filed Under: Big Data, Cardiovascular, Featured, Wall Street Beat Tagged With: nvidia, Scripps Research Institute

ACC ’18 Roundup: Abbott releases long-term HeartMate 3 data

March 12, 2018 By Sarah Faulkner

Abbott (NYSE:ABT) touted two-year data yesterday from its trial designed to compare the company’s HeartMate 3 left ventricular assist device to its HeartMate 2 device in patients with advanced heart failure. Data from the study were published in The New England Journal of Medicine and presented at the American College of Cardiology’s 67th Annual Scientific Session. More […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Diagnostics, Food & Drug Administration (FDA), Regulatory/Compliance, Research & Development, Structural Heart, Vascular, Wall Street Beat Tagged With: Abbott, Aetna, AliveCor, iRhythm Technologies Inc., Janssen Pharmaceuticals, Medtronic, OrbusNeich, Philips, Scripps Research Institute, Zoll Medical

Researchers progress towards vaccine against fentanyl, heroin combo

August 21, 2017 By Sarah Faulkner

Researchers reported at the 254th National Meeting & Exposition of the American Chemical Society today that they are developing a vaccine to guard against the effects of fentanyl in combination with heroin – a deadly duo that is claiming a growing number of lives as the opioid crisis worsens in the U.S. “There is an […]

Filed Under: Pain Management, Pharmaceutical, Research & Development Tagged With: Scripps Research Institute

SonoSite taps new CFO | Personnel Moves

January 2, 2012 By MassDevice staff Leave a Comment

SonoSite

SonoSite (NSDQ: SONO) said it’s replacing retiring CFO Marcus Smith with Anil Amlani, head of its VisualSonics subsidiary.

Smith’s last day as the ultrasound device maker’s top financial mind is today; he’s slated to stay on at the Bothell, Wash.-based company until Jan. 5, according to a press release.

Smith had been with SonoSite since 2007, according to the release.

Filed Under: News Well, Ultrasound Tagged With: Boston Scientific, BSD Medical Corp., Delcath Systems Inc., Fujifilm, Hanger Inc., Integra LifeSciences, Personnel Moves, Scripps Research Institute, wrightmedical, Zoll Medical

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy